Calreticulin exposure increases cancer immunogenicity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Biotechnology

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt0207-192PMID 17287754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A better way for a cancer cell to die.

  2006cited by this paper
• Necrotic death as a cell fate.

  2006cited by this paper
• Clearance of apoptotic and necrotic cells and its immunological consequences

  2006cited by this paper
• Mechanisms of immune evasion by tumors.

  2006cited by this paper
• Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

  2005cited by this paper
• Rational approaches to human cancer immunotherapy

  2003cited by this paper
• The phosphatidylserine receptor: a crucial molecular switch?

  2001cited by this paper

• Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity

  2025cites this paper
• Advancements in research and clinical management of interstitial lung injury associated with ADC drugs administration in breast cancer

  2024cites this paper
• Calreticulin-driven autophagy enhances cell proliferation in laryngeal squamous cell carcinoma.

  2024cites this paper
• Integration of ubiquitination-related genes in predictive signatures for prognosis and immunotherapy response in sarcoma

  2024cites this paper
• Unveiling the Therapeutic Potential and Mechanisms of Stanniocalcin-1 in Retinal Degeneration.

  2024cites this paper
• Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer

  2024cites this paper
• Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors

  2024cites this paper
• Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer.

  2024cites this paper
• Photodynamic therapy with paclitaxel-encapsulated indocyanine green-modified liposomes for breast cancer

  2024cites this paper
• NIR-II Light Evokes DNA Cross-linking for Chemotherapy and Immunogenic Cell Death.

  2023cites this paper
• “Spark” PtMnIr Nanozymes for Electrodynamic‐Boosted Multienzymatic Tumor Immunotherapy

  2023cites this paper
• A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal

  2023cites this paper
• Calreticulin: a quintessential multifaceted protein with therapeutic potential

  2023cites this paper
• Pyroptosis: A road to next-generation cancer immunotherapy.

  2023cites this paper
• Co-delivery of proanthocyanidin and mitoxantrone induces synergistic immunogenic cell death to potentiate cancer immunotherapy.

  2022cites this paper
• Calreticulin as a marker and therapeutic target for cancer

  2022cites this paper
• Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy.

  2022cites this paper
• Targeting CD47 as a Novel Immunotherapy for Breast Cancer

  2022cites this paper
• Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade

  2022cites this paper
• Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment.

  2021cites this paper
• Mechanisms of immunogenic cell death and immune checkpoint blockade therapy

  2021cites this paper
• Bioinformatics analysis for the role of CALR in human cancers

  2021cites this paper
• Cascade-Responsive Hierarchical Nanosystems for Multisite Specific Drug Exposure and Boosted Chemoimmunotherapy.

  2021cites this paper
• Exposure of a specific pleioform of multifunctional glyceraldehyde 3-phosphate dehydrogenase initiates CD14-dependent clearance of apoptotic cells

  2021cites this paper
• Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death

  2021cites this paper
• Self-adjuvanting photosensitizer nanoparticles for combination photodynamic immunotherapy.

  2021cites this paper
• Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.

  2021cites this paper
• An Emerging Approach for Combination Therapy of Cancer: The Role of Immunogenic Cell Death

  2020cites this paper
• Expression Analysis in the Transcription Level of PTGS2, CALR, MAGE-A3 Genes in Non-Small Cell Lung Cancer

  2020cites this paper
• Engineering Prodrug Nanomedicine for Cancer Immunotherapy

  2020cites this paper
• Cytotoxic T Cell Responses Induced by CS1/CRT Fusion DNA Vaccine in a Human Plasmacytoma Model

  2020cites this paper
• Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome

  2020cites this paper
• Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy.

  2020cites this paper
• Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death

  2020cites this paper
• Preface: Endoplasmic reticulum in health and disease.

  2020cites this paper
• Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation.

  2019cites this paper
• Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy

  2019cites this paper
• Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes

  2019cites this paper
• Stress‐induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy

  2018cites this paper
• Myeloid‐Derived Suppressor Cell Membrane‐Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death

  2018cites this paper
• Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.

  2017cites this paper
• Phagocytosis of Extracellular Vesicles Extruded From the Placenta by Ovarian Cancer Cells Inhibits Growth of the Cancer Cells

  2017cites this paper
• Calreticulin Release at an Early Stage of Death Modulates the Clearance by Macrophages of Apoptotic Cells

  2017cites this paper
• Calreticulin, a therapeutic target?

  2016cites this paper
• The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis

  2016cites this paper
• Tumor cells surface-engineered with polymeric particles for use as cancer vaccines

  2016cites this paper
• Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication.

  2016cites this paper
• Detection of cell surface calreticulin as a potential cancer biomarker using near-infrared emitting gold nanoclusters

  2016cites this paper
• The impact of subcellular location on the near infrared-mediated thermal ablation of cells by targeted carbon nanotubes

  2016cites this paper
• Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

  2015cites this paper
• Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272.

  2015cites this paper
• Agarose gel shift assay reveals that calreticulin favors substrates with a quaternary structure in solution.

  2015cites this paper
• Implantation of Liquid Nitrogen Frozen Tumor Tissue after Posterior Decompression and Stabilization for Metastatic Spinal Tumors

  2015cites this paper
• Functional Roles of Calreticulin in Cancer Biology

  2015cites this paper
• 12: Common Features of Oxidative Stress and Metabolic Impairments in Human Erythrocytes and Nucleated Cells

  2014cites this paper
• The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation

  2013influential citation
• Chapter 24 – Immune Stimulatory Features of Classical Chemotherapy

  2013cites this paper
• Calreticulin and Cancer

  2013cites this paper
• Recombinant murine calreticulin fragment 39-272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice.

  2013cites this paper
• Immune Stimulatory Features of Classical Chemotherapy

  2013cites this paper
• Assembly and characterization of a cell-particle hybrid system as a potential cancer vaccine

  2013cites this paper
• Wogonin Induced Calreticulin/Annexin A1 Exposure Dictates the Immunogenicity of Cancer Cells in a PERK/AKT Dependent Manner

  2012cites this paper
• The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation.

  2012cites this paper
• Nerve Growth Factor Induces the Expression of Chaperone Protein Calreticulin in Human Epithelial Ovarian Cells

  2012cites this paper
• Modulation of cellular immunity by antibodies against calreticulin

  2012cites this paper
• 7, 8-diacetoxy-4-methylcoumarin induced cell death in human tumor cells is influenced by calreticulin.

  2011cites this paper
• Modulatory role of calreticulin as chaperokine for dendritic cell‐based immunotherapy

  2011cites this paper
• Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.

  2011cites this paper
• Clinicopathological significance of calreticulin in breast invasive ductal carcinoma

  2010cites this paper
• Calreticulin in Health and Disease for Immunobiological Activities of 272: Implications - Calreticulin Fragment 39 Functional Analysis of Recombinant

  2010cites this paper
• Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.

  2010cites this paper
• Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction.

  2010cites this paper
• Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

  2010cites this paper
• Enhanced calreticulin expression triggers apoptosis in the MCF-7 cell line.

  2010cites this paper
• Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

  2010cites this paper
• Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010

  2010cites this paper
• Functional Analysis of Recombinant Calreticulin Fragment 39–272: Implications for Immunobiological Activities of Calreticulin in Health and Disease

  2010cites this paper
• Calreticulin is a B cell molecular target in some gastrointestinal malignancies

  2009cites this paper
• Antineoplastic activity of idazoxan hydrochloride

  2009cites this paper
• Radiation induces an antitumour immune response to mouse melanoma

  2009cites this paper
• Title Antineoplastic activity of idazoxan hydrochloride Permalink

  2009cites this paper
• The role of apoptosis and removal of apoptotic cells in the genesis of systemic lupus erythematosus

  2009cites this paper
• ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin1

  2008cites this paper
• Cancérogenèse. Accroissement des connaissances et évolution des concepts

  2008cites this paper
• Anticancer immunotherapy in combination with proapoptotic therapy.

  2008influential citation
• Ecto‐calreticulin in immunogenic chemotherapy

  2007influential citation
• high-dose melphalan systemic light-chain ( AL-) amyloidosis is associated with response to Calreticulin expression in the clonal plasma cells of patients with

  2007cites this paper
• Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

  2007cites this paper
• Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.

  2007cites this paper